Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates

Go back to Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates

Equillium (EQ) Reports Q4 Loss of $0.36/sh

March 23, 2022 4:03 PM EDT

Equillium (NASDAQ: EQ) reported Q4 EPS of ($0.36), versus ($0.36) reported last year.

For earnings history and earnings-related data on Equillium (EQ) click here.

... More